| NCT Number | NCT05663502 |
| Lead Sponsor | AIDS Malignancy Consortium
Collaborators: National Cancer Institute (NCI) |
| Conditions | Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection, Kaposi Sarcoma, Lymphoma, Malignant Solid Neoplasm, Multicentric Castleman Disease, Plasmablastic Lymphoma +4 more |
| Enrollment | 200 participants |
| Start Date | 2023-05-10 |
| Primary Completion | 2030-08-31 (estimated) |
| Study Completion | 2035-08-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-01 |